Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Pharmaceutical Sciences|July 6, 2004
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenololH Vogelpoel, J Welink, G L Amidon, et al.Journal of Pharmaceutical Sciences|April 15, 2011
Biowaiver monographs for immediate release solid oral dosage forms: lamivudineS Strauch, E Jantratid, J B Dressman, et al.Journal of Pharmaceutical Sciences|July 6, 2010
Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochlorideS Strauch, E Jantratid, J B Dressman, et al.Journal of Pharmaceutical Sciences|March 28, 2007
Biowaiver monographs for immediate release solid oral dosage forms: prednisoneM Vogt, H Derendorf, J Krämer, et al.Journal of Pharmaceutical Sciences|February 14, 2008
Biowaiver monographs for immediate release solid oral dosage forms: pyrazinamideC Becker, J B Dressman, G L Amidon, et al.Journal of Pharmaceutical Sciences|November 23, 2006
Biowaiver monographs for immediate release solid oral dosage forms: isoniazidC Becker, J B Dressman, G L Amidon, et al.Journal of Pharmaceutical Sciences|September 20, 2007
Biowaiver monographs for immediate release solid oral dosage forms: ethambutol dihydrochlorideC Becker, J B Dressman, G L Amidon, et al.Journal of Pharmaceutical and Biomedical Analysis|July 31, 2009
Risk analysis by FMEA as an element of analytical validationJ F van Leeuwen, M J Nauta, D de Kaste, et al.Journal of Pharmaceutical Sciences|December 5, 2009
Biowaiver monographs for immediate release solid oral dosage forms: furosemideG E Granero, M R Longhi, M J Mora, et al.Journal of Pharmaceutical and Biomedical Analysis|October 26, 2010
Consistency of FMEA used in the validation of analytical proceduresM T Oldenhof, J F van Leeuwen, M J Nauta, et al.Pageof 5